NICE Guidelines: Pancreatitis

NICE Guidelines: Pancreatitis, published Sep 2018 and updated Dec 2020

The BSG endorse this guideline and were stakeholders in its development.

This guideline covers managing acute and chronic pancreatitis in children, young people and adults. It aims to improve quality of life by ensuring that people have the right treatment and follow-up, and get timely information and support after diagnosis.

MHRA safety update on insulins: In December 2020, we highlighted the importance of rotating insulin injection sites within the same body region, in line with an MHRA Drug Safety Update on insulins (all types): risk of cutaneous amyloidosis at injection site.

Read More

BSG logo
Guidance
Care Bundles
Liver
Decompensated cirrhosis: an update of the BSG/BASL admission care bundle
clinical-resource/Decompensated-Liver-Disease-CB-2025-update
This document was published in 2025.

BSG logo
Position Statements
Inflammatory Bowel Disease
The 2025 British Society for Rheumatology guideline for the treatment of axial spondyloarthritis with biologic and targeted synthetic DMARDs
clinical-resource/BSR-guideline-axial-spondyloarthritis-DMARDs